title: Letter: Supporting Austrian guidelines on latent tuberculosis screening.
authors.forename: R K
authors.initials: RK
authors.lastname: Magalhães
authors.forename: M
authors.initials: M
authors.lastname: Salgado
authors.forename: P
authors.initials: P
authors.lastname: Lago
authors.forename: T
authors.initials: T
authors.lastname: Moreira
authors.forename: M
authors.initials: M
authors.lastname: Magalhães
authors.forename: P
authors.initials: P
authors.lastname: Salgueiro
authors.forename: I
authors.initials: I
authors.lastname: Pedroto
mesh_terms: D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D055985:Latent Tuberculosis / Q000175:diagnosis*; D008297:Male; D014374:Tuberculin Test / Q000379:methods*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha